Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

[Impact of metabolic syndrome in the control of blood pressure and dyslipemia].

Rodilla E, García L, Merino C, Costa JA, González C, Pascual JM.

Med Clin (Barc). 2004 Nov 6;123(16):601-5. Spanish.

PMID:
15546516
3.

Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.

Chopra I, Kamal KM.

Hosp Pract (1995). 2014 Apr;42(2):77-88. doi: 10.3810/hp.2014.04.1106.

PMID:
24769787
4.

[Adequacy of the treatment of hypertensive patients with metabolic syndrome].

Barrios V, Escobar C, Calderón A, Llisterri JL, Alegría E, Muñiz J, Matalí A.

Med Clin (Barc). 2007 May 5;128(17):647-51. Spanish.

PMID:
17537361
5.

Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control.

Magen E, Viskoper R, Mishal J, Priluk R, Berezovsky A, Laszt A, London D, Yosefy C.

Isr Med Assoc J. 2004 Dec;6(12):742-6.

6.
8.

Treatment of Hypertension: Which Goal for Which Patient?

Jarraya F.

Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97. Review.

PMID:
27722961
9.

Glycaemic, blood pressure and cholesterol control in 25 629 diabetics.

Pinchevsky Y, Butkow N, Chirwa T, Raal FJ.

Cardiovasc J Afr. 2015 Jul-Aug;26(4):188-92. doi: 10.5830/CVJA-2015-050. Review.

11.

Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.

Corcillo A, Pivin E, Lalubin F, Pitteloud N, Burnier M, Zanchi A.

Swiss Med Wkly. 2017 Jul 6;147:w14459. doi: 10.4414/smw.2017.14459. eCollection 2017.

12.

Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice.

Di Martino M, Degli Esposti L, Filigheddu F, Veronesi C, Salerno G, Saragoni S, Glorioso N, Didoni G, Degli Esposti E.

J Hum Hypertens. 2007 Jan;21(1):53-9. Epub 2006 Oct 12.

PMID:
17036042
13.

Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.

Roman MJ, Howard BV, Howard WJ, Mete M, Fleg JL, Lee ET, Devereux RB.

Hypertension. 2011 Sep;58(3):367-71. doi: 10.1161/HYPERTENSIONAHA.111.172486. Epub 2011 Jul 25.

14.

Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.

Howard BV, Roman MJ, Devereux RB, Fleg JL, Galloway JM, Henderson JA, Howard WJ, Lee ET, Mete M, Poolaw B, Ratner RE, Russell M, Silverman A, Stylianou M, Umans JG, Wang W, Weir MR, Weissman NJ, Wilson C, Yeh F, Zhu J.

JAMA. 2008 Apr 9;299(14):1678-89. doi: 10.1001/jama.299.14.1678.

15.
16.

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP.

JAMA. 2013 Jun 5;309(21):2240-9. doi: 10.1001/jama.2013.5835.

17.

Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.

Rodrigues CJ, Ribeiro HF, Ribeiro AB, Zanella MT, Batista MC.

Metab Syndr Relat Disord. 2012 Jun;10(3):195-201. doi: 10.1089/met.2011.0133. Epub 2012 Feb 7.

PMID:
22313142
18.

Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients.

Kanbay M, Yildirir A, Bozbas H, Ulus T, Bilgi M, Muderrisoglu H, Akcay A, Ozdemir FN.

Ren Fail. 2005;27(3):297-303.

PMID:
15957546
19.

Blood pressure and other cardiovascular risk factors among treated hypertensives in Swedish primary health care.

Cederholm J, Nilsson PM, Anderberg CP, Fröberg L, Petersson U; Q-Heart Study Group.

Scand J Prim Health Care. 2002 Dec;20(4):224-9.

PMID:
12564574
20.

[C-reactive protein changes with antihypertensive and statin treatment].

Rodilla E, Gómez-Belda A, Costa JA, Aragó M, Miralles A, González C, Pascual JM.

Med Clin (Barc). 2005 Oct 29;125(15):561-4. Spanish.

PMID:
16277947

Supplemental Content

Support Center